Literature DB >> 6318312

The thymus-adrenal connection: thymosin has corticotropin-releasing activity in primates.

D L Healy, G D Hodgen, H M Schulte, G P Chrousos, D L Loriaux, N R Hall, A L Goldstein.   

Abstract

Endotoxin-free thymosin fraction 5 elevated corticotropin, beta-endorphin, and cortisol in a dose- and time-dependent fashion when administered intravenously to prepubertal cynomolgus monkeys. Two synthetic component peptides of thymosin fraction 5 had no acute effects on pituitary function, suggesting that some other peptides in thymosin fraction 5 were responsible for its corticotropin-releasing activity. In agreement with these observations, total thymectomy of juvenile macaques was associated with decreases in plasma cortisol, corticotropin, and beta-endorphin. These findings indicate that the prepubertal primate thymus contains corticotropin-releasing activity that may contribute to a physiological immunoregulatory circuit between the developing immunological and pituitary-adrenal systems.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6318312     DOI: 10.1126/science.6318312

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  5 in total

1.  Influence of thymosin (fraction 5) and tactivin on the function of the adrenal cortex in mice.

Authors:  E V Ignat'eva; V M Chesnokova; L N Ivanova
Journal:  Neurosci Behav Physiol       Date:  1991 Nov-Dec

2.  Influence of thymosin on the formation of the functional activity of the adrenals in mice.

Authors:  V M Chesnokova; E V Ignat'eva; L N Ivanova; O M Tepelina; V A Livshits; G K Korotaev
Journal:  Neurosci Behav Physiol       Date:  1987 Jul-Aug

Review 3.  Thymosins and anti-thymosins: properties and clinical applications.

Authors:  A L Goldstein; R S Schulof; P H Naylor; N R Hall
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

4.  Effects of prenatal exposure to delta-9-tetrahydrocannabinol on reproductive, endocrine and immune parameters of male and female rat offspring.

Authors:  L L Murphy; J Gher; A Szary
Journal:  Endocrine       Date:  1995-12       Impact factor: 3.633

5.  Rationale for thymopentin as therapeutic agent in rheumatoid arthritis.

Authors:  P Franchimont; K Bolla
Journal:  Surv Immunol Res       Date:  1985
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.